What is the relative weight of MS-DRG 732 for FY2027?

1.9208. The relative weight is multiplied by the hospital's blended base rate to produce the payment, so above 1.0 means above-average reimbursement for the stay.

What is the length of stay for MS-DRG 732?

The FY2027 geometric mean length of stay is 3.00 days and the arithmetic mean is 3.90 days. The geometric mean is the one CMS uses for the post-acute transfer policy, which does not apply to this DRG.

Which diagnoses group to MS-DRG 732?

58 ICD-10-CM codes are routed to MS-DRGs 731–733 as principal diagnosis in the CMS MS-DRG definitions manual; which of 731–733 the case lands in depends on whether a secondary diagnosis qualifies as a CC or MCC. The most-searched are C54.1 (malignant neoplasm of endometrium), C55 (malignant neoplasm of uterus, part unspecified), C56.9 (malignant neoplasm of unspecified ovary), C53.9 (malignant neoplasm of cervix uteri, unspecified), D06.9 (carcinoma in situ of cervix, unspecified).

732

MS-DRG 732 — UTERINE AND ADNEXA PROCEDURES FOR MALIGNANCY WITH CC

DRGSurgicalMDC 13

MS-DRG 732 is uterine and adnexa procedures for malignancy with cc, in MDC 13 (a surgical DRG), at the with-CC (complication or comorbidity) level. Its FY2027 relative weight is 1.9208, so a case here pays more than the average Medicare inpatient stay (weight 1.0), with a geometric mean length of stay of 3.00 days. 58 ICD-10-CM principal diagnoses group into MS-DRGs 731–733 under the CMS definitions manual; the most-searched are listed below.

FY2027 payment factors

Relative weight: 1.9208
Geometric mean LOS: 3.00
Arithmetic mean LOS: 3.90
Post-acute transfer: No

Principal diagnoses that group to MS-DRGs 731–733

From the CMS MS-DRG definitions manual’s principal-diagnosis index: 58 ICD-10-CM codes route here, and the CC/MCC status of the secondary diagnoses decides which of 731–733 the case lands in. The 24 most-searched:

C54.1Malignant neoplasm of endometrium
C55Malignant neoplasm of uterus, part unspecified
C56.9Malignant neoplasm of unspecified ovary
C53.9Malignant neoplasm of cervix uteri, unspecified
D06.9Carcinoma in situ of cervix, unspecified
C56.1Malignant neoplasm of right ovary
C56.3Malignant neoplasm of bilateral ovaries
C51.9Malignant neoplasm of vulva, unspecified
C52Malignant neoplasm of vagina
C53.0Malignant neoplasm of endocervix
C53.8Malignant neoplasm of overlapping sites of cervix uteri
C54.9Malignant neoplasm of corpus uteri, unspecified
C79.82Secondary malignant neoplasm of genital organs
D07.1Carcinoma in situ of vulva
C53.1Malignant neoplasm of exocervix
C56.2Malignant neoplasm of left ovary
C58Malignant neoplasm of placenta
C76.3Malignant neoplasm of pelvis
D06.0Carcinoma in situ of endocervix
D07.0Carcinoma in situ of endometrium
D39.0Neoplasm of uncertain behavior of uterus
C51.0Malignant neoplasm of labium majus
C51.1Malignant neoplasm of labium minus
C51.2Malignant neoplasm of clitoris

34 more codes group here. Open any code above for its full hierarchy, or check a whole claim in the free DRG calculator.

Common questions

What is MS-DRG 732?: MS-DRG 732 is uterine and adnexa procedures for malignancy with cc, in MDC 13 (a surgical DRG), at the with-CC (complication or comorbidity) level. Its FY2027 relative weight is 1.9208, so a case here pays more than the average Medicare inpatient stay (weight 1.0), with a geometric mean length of stay of 3.00 days. 58 ICD-10-CM principal diagnoses group into MS-DRGs 731–733 under the CMS definitions manual; the most-searched are listed below.
What is the relative weight of MS-DRG 732 for FY2027?: 1.9208. The relative weight is multiplied by the hospital's blended base rate to produce the payment, so above 1.0 means above-average reimbursement for the stay.
What is the length of stay for MS-DRG 732?: The FY2027 geometric mean length of stay is 3.00 days and the arithmetic mean is 3.90 days. The geometric mean is the one CMS uses for the post-acute transfer policy, which does not apply to this DRG.
Which diagnoses group to MS-DRG 732?: 58 ICD-10-CM codes are routed to MS-DRGs 731–733 as principal diagnosis in the CMS MS-DRG definitions manual; which of 731–733 the case lands in depends on whether a secondary diagnosis qualifies as a CC or MCC. The most-searched are C54.1 (malignant neoplasm of endometrium), C55 (malignant neoplasm of uterus, part unspecified), C56.9 (malignant neoplasm of unspecified ovary), C53.9 (malignant neoplasm of cervix uteri, unspecified), D06.9 (carcinoma in situ of cervix, unspecified).

Other DRGs in MDC 13

The with-MCC, with-CC and without-CC/MCC splits usually sit next to each other here. Those are what a documentation query is actually deciding between, and the weight gap between them is why the query is worth raising.

731UTERINE AND ADNEXA PROCEDURES FOR MALIGNANCY WITH MCC3.5478
733UTERINE AND ADNEXA PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC1.4324
734PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC1.9170
735PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC1.2110
742UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC1.8456
743UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC1.2974
744D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC2.0619
745D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC1.0659
746VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC1.6250
747VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC0.8675
748FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES1.3810
749OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC2.4715
750OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC1.4952
754MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC1.8092
755MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC1.1490
756MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC0.8645
757INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC1.4649
758INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC0.9908
759INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC0.7691
760MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC1.0129
761MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC0.7041

Working the claim behind this DRG

A DRG is assigned from the diagnoses and procedures already on the claim, so the questions that decide MS-DRG 732 are coding questions. Look the principal diagnosis up in the full ICD-10-CM tabular list with its Excludes1 and “code first” notes attached, or start from the condition instead of the code in the codes-by-condition index. For the secondary diagnoses that move a case between the with-MCC, with-CC and without-CC/MCC splits, paste the whole set into the free claim scrubber and see which pairs collide before the claim goes out — no account, no card.

The supplies, drugs and devices billed alongside an inpatient stay are HCPCS Level II, listed in full at HCPCS by section. If the claim comes back rejected, the denial code index explains what each CARC actually means and what to do about it, and the decision guides walk the sequencing calls that most often cause one — sepsis and diabetes above all.

Every one of those is free and needs no account. This page is the payment table: it says what MS-DRG 732 is worth. Which medical DRG a set of diagnoses lands in is the workspace’s DRG impact check, from the CMS CC/MCC lists; it does not group surgical cases.